Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pierre Nahon

Showing results (31-40 of 205) with videos related to

Pageof 21
Sort By:
Journal of Hepatology|April 4, 2016
PNPLA3 gene in liver diseasesEric Trépo, Stefano Romeo, Jessica Zucman-Rossi, et al.
Hepatic Oncology|March 8, 2021
Characterizing the mechanism behind the progression of NAFLD to hepatocellular carcinomaPierre Nahon, Manon Allaire, Jean-Charles Nault, et al.
Journal of Viral Hepatitis|October 27, 2019
Comparing interferon-free with interferon-based regimens in HCV patients: Rogers phenomenon and Simpson's paradoxFabrice Carrat, Pierre Nahon, Hélène Fontaine, et al.
Radiology|October 19, 2017
Is "Segmentectomy" a Suitable Term to Use in Patients Undergoing Hepatic Segmental <sup>90</sup>Y Radioembolization for the Treatment of Hepatocellular Carcinoma Up to 3 cm?Olivier Seror, Jean-Charles Nault, Gisele N'Kontchou, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|December 26, 2022
Immunotherapy in hepatocellular carcinoma: How does underlying liver disease influence therapeutic strategy and outcomes?Gael S Roth, François Villeret, Thomas Decaens, et al.
The American Journal of Gastroenterology|July 4, 2002
Stump appendicitis diagnosed by colonoscopyPierre Nahon, Stéphane Nahon, Jean-Marc Hoang, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|November 13, 2015
In alcoholic cirrhosis, low-serum hepcidin levels associate with poor long-term survivalPierre Nahon, Renwar Nuraldeen, Pierre Rufat, et al.
Gastroenterology|November 26, 2018
ReplyCharlotte E Costentin, Richard Layese, Françoise Roudot-Thoraval, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|October 17, 2023
Measuring the impact of the updated Steatotic liver disease nomenclature and definitionLuca Valenti, Alessio Aghemo, Alejandro Forner, et al.
Anaesthesia, Critical Care & Pain Medicine|October 11, 2025
Cirrhosis is an independent risk factor for candidemia in critically ill patients: A 6-year single-center observational studyMohamed Ghalayini, Cécile Zylberfajn, Pierre Nahon, et al.
Pageof 21

Showing results (31-40 of 205) with videos related to

Sort By:
Pageof 21
Journal of Hepatology|April 4, 2016
PNPLA3 gene in liver diseasesEric Trépo, Stefano Romeo, Jessica Zucman-Rossi, et al.
Hepatic Oncology|March 8, 2021
Characterizing the mechanism behind the progression of NAFLD to hepatocellular carcinomaPierre Nahon, Manon Allaire, Jean-Charles Nault, et al.
Journal of Viral Hepatitis|October 27, 2019
Comparing interferon-free with interferon-based regimens in HCV patients: Rogers phenomenon and Simpson's paradoxFabrice Carrat, Pierre Nahon, Hélène Fontaine, et al.
Radiology|October 19, 2017
Is "Segmentectomy" a Suitable Term to Use in Patients Undergoing Hepatic Segmental <sup>90</sup>Y Radioembolization for the Treatment of Hepatocellular Carcinoma Up to 3 cm?Olivier Seror, Jean-Charles Nault, Gisele N'Kontchou, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|December 26, 2022
Immunotherapy in hepatocellular carcinoma: How does underlying liver disease influence therapeutic strategy and outcomes?Gael S Roth, François Villeret, Thomas Decaens, et al.
The American Journal of Gastroenterology|July 4, 2002
Stump appendicitis diagnosed by colonoscopyPierre Nahon, Stéphane Nahon, Jean-Marc Hoang, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|November 13, 2015
In alcoholic cirrhosis, low-serum hepcidin levels associate with poor long-term survivalPierre Nahon, Renwar Nuraldeen, Pierre Rufat, et al.
Gastroenterology|November 26, 2018
ReplyCharlotte E Costentin, Richard Layese, Françoise Roudot-Thoraval, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|October 17, 2023
Measuring the impact of the updated Steatotic liver disease nomenclature and definitionLuca Valenti, Alessio Aghemo, Alejandro Forner, et al.
Anaesthesia, Critical Care & Pain Medicine|October 11, 2025
Cirrhosis is an independent risk factor for candidemia in critically ill patients: A 6-year single-center observational studyMohamed Ghalayini, Cécile Zylberfajn, Pierre Nahon, et al.
Pageof 21